shutterstock_1399766828_jisoo_song
12 December 2023FeaturesAsiaYoung Kim, Yu-Seog WON, In Hwan Kim and Amy (Seung-Hyun) Oh

Why did a South Korea court invoke the ‘extraterritorial activity’ exception in Prevenar 13 case?

In a patent infringement action filed by Pfizer, the Seoul Central District Court rendered a decision finding that another pharmaceutical company directly infringed Pfizer's composition patent—even though the infringer did not make the patented composition in Korea.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
31 August 2021   South Korean officials have urged the US government to help Korean companies gain access to IP related to producing COVID-19 jabs.
Big Pharma
16 March 2021   Healthcare innovation led patenting activity in 2020 as COVID-19 fuelled a rise in applications, a report by the European Patent Office has revealed.